Scott Ribich PhD

Scott Ribich is Vice President of Biology, overseeing all aspects of discovery biology at Accent Therapeutics. Scott joins Accent with over 10 years of target discovery and drug development experience in both small biotech and large pharma. Prior to joining Accent, Scott was Director of Biology at Epizyme, where he was responsible for leading teams involved with target identification, drug discovery and clinical candidate support. He started his career in drug discovery at GlaxoSmithKline and Sirtris Pharmaceuticals, where he worked on multiple early-stage and clinical-stage assets. Scott holds a B.S. in biology from Massachusetts Institute of Technology, a Ph.D. in biochemistry from Harvard University and completed his postdoctoral training at Harvard Medical School and Brigham and Women’s Hospital.